Atlas Trials

A Study of Diarrhea and Intestinal Flora Changes Caused by Pyrotinib in Breast Cancer

Clinical trial NCT05030519 · UNKNOWN

Trial details

NCT number
NCT05030519
Sponsor
Zhejiang Cancer Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
Breast Cancer
Start date
2021-01-18
Primary completion
2022-06-30
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.